arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

download Export Data

Innovative Eyewear Inc

LUCY

$0.72 ▲ +0.01 (+0.85%) at close

22 Visible periods

22 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Innovative Eyewear Inc faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $4.5M

Dividend Yield —

Revenue Growth 70.2% ↗

Op. Margin —

ROIC —

FCF / Share $-0.40

Trailing P/E —

Price / Book 0.5x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

22-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$773.56K

↑ +70.2% —

Net Income Profit after all expenses

$-2.31M

↓ -29.8% —

FCF / Share Free cash flow per share

$-0.40

↑ +58.4% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Profit Margin (%)Profit Margin (%) is in the bottom quartile
Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability →

Returns ↑

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 5 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Dec 31, 2020 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
Revenue Growth YoY (%)	70.2% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1304%)	39.0% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+679%)	163.5% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+3169%)	87.6% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1653%)	18.5% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+270%)	12.2% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+143%)	14.3% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+186%)	81.7% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1533%)	164.6% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+3192%)	818.1% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+16262%)	46.0% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+820%)	-17.0% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-440%)	-38.6% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-872%)	-75.7% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1613%)	-11.2% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-323%)	61.2% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1124%)	—	—	—	—	—	—
EPS Growth YoY (%)	48.6% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	31.7% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	61.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	64.7% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-380.0% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	88.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-725.0% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-1146.7% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	—	-1280.8% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	42.9% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	25.0% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-29.8% Weak ↓ Weak Declining Year-over-year change in net income	12.0% Fair ↑ Fair Improving Year-over-year change in net income	-6.7% Weak ↓ Weak Declining Year-over-year change in net income	-8.1% Weak ↓ Weak Declining Year-over-year change in net income	9.8% Fair ↑ Fair Improving Year-over-year change in net income	11.2% Fair ↑ Fair Improving Year-over-year change in net income	-20.3% Weak ↑ Weak Improving Year-over-year change in net income	-36.2% Weak ↓ Weak Declining Year-over-year change in net income	-37.8% Weak ↓ Weak Declining Year-over-year change in net income	—	-18.6% Weak → Weak Stable Year-over-year change in net income	-18.6% Weak ↑ Weak Improving Year-over-year change in net income	-18.6% Weak ↑ Weak Improving Year-over-year change in net income	—	-444.2% Weak Weak Year-over-year change in net income	-124.9% Weak Weak Year-over-year change in net income	—	—	—	—	—	—
FCF Growth YoY (%)	58.4% Excellent Excellent Year-over-year change in free cash flow	—	—	—	-727.9% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	74.8% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	142.8% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	63.8% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	41.4% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	24.4% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	35.9% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	14.0% Good Good Compound annual revenue growth over 3 years	34.4% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Dec 31, 2020 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
Profit Margin (%) (%)	-298.5% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3832%)	-194.8% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2536%)	-274.8% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3535%)	-363.6% Weak → Weak Stable Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-4645%)	-391.4% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-4992%)	-307.8% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3948%)	—	—	—	-388.7% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-4959%)	—	—	—	—	—	—	—	—	-129.6% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1720%)	-422.4% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-5380%)	—	—
FCF Margin (%) (%)	-322.0% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-142.5% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-226.3% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-365.4% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	-285.2% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	-391.1% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-222.0% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	-250.8% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-280.9% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-150.2% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-280.1% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—
FCF / Net Income (x)	1.08x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.73x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.82x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.00x Fair ↓ Fair Declining Free cash flow relative to reported net income Optimal: > 1x	1.32x Good Good Free cash flow relative to reported net income Optimal: > 1x	0.93x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.76x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.57x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	1.02x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	—	0.85x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.43x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.55x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	2.16x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	—	—	—

🎯 Is capital allocation efficient? 1 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Dec 31, 2020 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
Return on Common Equity (%) (%)	-27.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-284%)	-20.6% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-238%)	-17.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-219%)	-18.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-225%)	-23.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-258%)	-23.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-256%)	-15.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-205%)	-26.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-277%)	-50.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-437%)	-43.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-387%)	-18.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-225%)	-16.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-207%)	-31.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-310%)	—	-21.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-244%)	89.2% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+495%)	207.3% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1282%)	—	—	—	—	—

⚖️ Is the balance sheet risky? 1 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Dec 31, 2020 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
Net Debt (USD)	$-4.38M	$-6.51M	$-6.70M	$-7.63M	$-5.26M	$-2.63M	$-4.54M	$-5.90M	$-2.65M	$-4.29M	$-3.90M	$-5.36M	$-3.45M	$-3.59M	—	—	—	$-79.73K	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Dec 31, 2020 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
Revenue per Share (USD)	$0.12	—	$0.14	$0.18	$0.19	—	$0.15	$0.30	$0.03	—	$0.02	$0.02	—	—	$0.02	$0.03	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.37	$-0.28	$-0.38	$-0.66	$-0.72	$-0.41	$-0.99	$-1.87	$-0.15	$-3.59	$-0.12	$-0.15	—	$-0.26	$-0.21	$-0.20	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.40	—	$-0.31	$-0.66	$-0.96	—	—	—	$-0.12	—	—	—	—	—	$-0.15	$-0.08	—	—	—	—	—	—
Book Value per Share (USD)	$1.33	$1.65	$1.97	$2.47	$3.06	$3.71	$4.52	$4.81	$0.29	$7.44	$0.59	$0.69	$0.59	$0.55	$0.83	$-0.22	—	$0.03	—	—	—	—
Tangible Book Value per Share (USD)	$1.33	$1.65	$1.97	$2.47	$3.06	$3.71	$4.52	$4.81	$0.29	$7.44	$0.59	$0.69	$0.59	$0.55	$0.83	$-0.22	—	$0.03	—	—	—	—
Basic Weighted Avg Shares (shares)	6.25M	—	4.87M	3.21M	2.45M	—	1.74M	1.04M	12.95M	—	12.92M	8.57M	—	—	6.67M	6.06M	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Dec 31, 2020 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
Working Capital (USD)	$7.66M	$8.39M	$9.71M	$10.73M	$6.88M	$8.50M	$10.34M	$6.79M	$3.23M	$4.99M	$7.07M	$8.44M	$4.04M	$3.64M	—	—	—	$27.53K	—	—	—	—
Total Equity (USD)	$8.37M	$9.07M	$10.25M	$11.28M	$7.49M	$9.10M	$10.93M	$7.34M	$3.90M	$5.56M	$7.64M	$8.95M	$4.55M	$4.02M	$5.57M	$-1.35M	$-582.09K	$207.52K	$30.87K	$104.48K	$-554.84K	$-554.84K

📋 What is driving earnings? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Dec 31, 2020 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
Sales/Revenue/Turnover (USD)	$773.56K	$959.81K	$668.13K	$579.23K	$454.50K	$690.69K	$253.60K	$308.68K	$383.47K	$615.75K	$221.88K	$169.93K	$144.92K	$67.07K	$151.96K	$204.74K	$236.02K	$275.49K	$171.03K	$127.03K	—	—
Depreciation Expense (USD)	$11.55K	$13.50K	$14.92K	$17.17K	$21.20K	$25.58K	$23.96K	$38.29K	$21.66K	$15.10K	$17.02K	$10.31K	$10.31K	$9.54K	$4.67K	$3.92K	$3.98K	$500.00	$0.00	$0.00	—	—
Net Income, GAAP (USD)	$-2.31M	$-1.87M	$-1.84M	$-2.11M	$-1.78M	$-2.13M	$-1.72M	$-1.95M	$-1.97M	$-2.39M	$-1.43M	$-1.43M	$-1.43M	—	$-1.21M	$-1.21M	$-1.21M	—	$-221.71K	$-536.60K	—	—
Operating Cash Flow (USD)	$-2.49M	$-1.35M	$-1.50M	$-2.12M	$-2.31M	$-1.94M	—	—	$-1.47M	$-1.34M	—	—	$-1.43M	$-1.12M	$-970.71K	$-505.24K	$-630.87K	$-403.71K	$-470.36K	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 6 years · 22 quarters

Innovative Eyewear Inc

Analytical Summary

22-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare LUCY with peers